RNA PCR SCREENING FOR HIV COULD HALVE SEROCONVERSION WINDOW TO 11 DAYS, FDA CONFERENCE TOLD; COST/BENEFIT RATIO IS POSSIBLE DRAWBACK TO DEVELOPMENT
This article was originally published in The Gray Sheet
Executive Summary
The use of RNA polymerase chain reaction screening for HIV could allow detection in blood donors 11 days earlier than third- generation anti-HIV-1/HIV-2 enzyme immunosorbent assays (EIAs), Michael Busch, MD, PhD, Irwin Memorial Blood Centers and University of California, San Francisco, told a Sept. 26-28 FDA conference.
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
Maxwellia Delivers Two UK Menstrual Health Rx-To-OTC Switches
UK switch specialist Maxwellia delivers two “me too” reclassifications in the area of women's health: Evana Heavy Period Relief and Ultravana Period Pain Relief.
WHO Examines Ethical Criteria For Human Challenge Trials Ahead Of Next Health Emergency
The World Health Organization is looking to finalize its guidance on the ethical criteria that should be applied to studies that involve deliberately infecting healthy individuals to speed up research.